Korean J Urol.  2015 May;56(5):365-369. 10.4111/kju.2015.56.5.365.

One day surgery in the treatment of benign prostatic enlargement with thulium laser: A single institution experience

• Carmignani L
• Macchi A
• Ratti D
• Finkelberg E
• Casellato
• Maruccia S
• Marenghi C
• Picozzi SC

• KMID: 2155316
• DOI: http://doi.org/10.4111/kju.2015.56.5.365

Abstract

PURPOSE
Various articles have previously addressed the introduction of new surgical laser therapies for an enlarged prostate gland causing obstructive symptoms. The objective of this study was to report the feasibility of performing the thulium laser vapo-enucleation of the prostate (ThuVEP) procedure for benign prostatic obstruction in a 1-day surgery.
MATERIALS AND METHODS
From September 2011 to September 2013, we conducted a prospective study on patients who underwent ThuVEP in a 1-day surgery. The primary outcomes measured perioperatively included operative time, resected tissue weight, hemoglobin decrease, transfusion rate, postoperative irrigation and catheterization time, and postoperative hospital stay. Also, the preoperative and postoperative International Prostate Symptom Score (IPSS) and results of uroflowmetry performed on the 7th and 30th postoperative days were recorded. All perioperative and postoperative complications were monitored.
RESULTS
A total of 53 patients underwent the surgical treatment in a 1-day surgery. Seven patients continued antiaggregant therapy with aspirin. Mean preoperative prostatic adenoma volume was 56.6 mL. Mean operative time was 71 minutes. The average catheter time was 14.8 hours. The peak urinary flow rate on day 7 improved from 9.3 to 17.42 mL/s (p<0.001) and the IPSS improved from 18 to 10.2 (p<0.01). Patients were routinely discharged on the day of catheter removal. No complications were recorded.
CONCLUSIONS
ThuVEP can be safely conducted as a 1-day surgical procedure. This strategy results in cost savings. ThuVEP shows good standardized outcomes with respect to improvement in flow parameters and length of bladder catheterization.

Keyword

Lasers; Prostate; Prostatic hyperplasia; Thulium

MeSH Terms

Aged
Ambulatory Surgical Procedures
Humans
Laser Therapy/adverse effects/*instrumentation
Lasers, Solid-State/*therapeutic use
Length of Stay
Male
Middle Aged
Operative Time
Prospective Studies
Prostate/*surgery
Prostatic Hyperplasia/*surgery
Thulium/*therapeutic use
Transurethral Resection of Prostate
Treatment Outcome
Thulium

Reference

1. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013; 64:118–140.

2. Osterberg EC, Choi BB. Review of current laser therapies for the treatment of benign prostatic hyperplasia. Korean J Urol. 2013; 54:351–358.

3. Bachmann A, Woo HH, Wyler S. Laser prostatectomy of lower urinary tract symptoms due to benign prostate enlargement: a critical review of evidence. Curr Opin Urol. 2012; 22:22–33.

4. Schroeck FR, Hollingsworth JM, Hollenbeck BK, Jacobs BL, Suskind AM, Sarma AV, et al. Differential adoption of laser prostatectomy for treatment of benign prostatic hyperplasia. Urology. 2013; 81:1177–1182.

5. Flannigan GM. Surgical equipment for benign prostate surgery: the relative merits of uniploar diathermy resection, plasma kinetic resection and laser vaporisation of the prostate. J Perioper Pract. 2012; 22:suppl 05, 7.

6. Xu Y, Sun D, Wei Z, Hong B, Yang Y. Clinical study on the application of a 2-µm continuous wave laser in transurethral vaporesection of the prostate. Exp Ther Med. 2013; 5:1097–1100.

7. Herrmann TR, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M, et al. Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol. 2010; 28:45–51.

8. Fried NM, Murray KE. High-power thulium fiber laser ablation of urinary tissues at 1.94 microm. J Endourol. 2005; 19:25–31.

9. Fried NM. High-power laser vaporization of the canine prostate using a 110 W Thulium fiber laser at 1.91 microm. Lasers Surg Med. 2005; 36:52–56.

10. Carmignani L, Lunelli L, Bozzini G, Picozzi S, Casellato S. Comparison between monopolar trans-urethral resection of prostate and thulium laser enucleation of the prostate: a single institution experience. Urology. 2012; 80:s72.

11. Fraundorfer MR, Gilling PJ, Kennett KM, Dunton NG. Holmium laser resection of the prostate is more cost effective than transurethral resection of the prostate: results of a randomized prospective study. Urology. 2001; 57:454–458.

12. Liatsikos E, Kyriazis I, Kallidonis P, Sakellaropoulos G, Maniadakis N. Photoselective GreenLight TM laser vaporization versus transurethral resection of the prostate in Greece: a comparative cost analysis. J Endourol. 2012; 26:168–173.